Johannes Fruehauf

A physician and biotech entrepreneur, Johannes Fruehauf was born in Germany. He studied medicine in Germany and France and completed fieldwork in Zimbabwe and Guinea. In 2002, he moved to Boston for a postdoctoral research fellowship at Harvard Medical School and the Beth Israel Deaconess Medical Center.

Fruehauf has spent more than 20 years building innovative life sciences companies. He is founder and chairman of LabCentral, a pioneering incubator for life sciences startups, and founder and president of BioLabs, a global provider of laboratory coworking spaces. Together, BioLabs and LabCentral have helped launch hundreds of companies that routinely raise billions of dollars in venture capital. Fruehauf is also cofounder and general partner at Mission BioCapital. He is the author of more than 30 peer-reviewed publications and has been named an inventor on nine patents spanning drug delivery and RNAi-based therapeutics.

An advocate for the role of immigrants in innovation, Fruehauf  wrote in STAT News in 2017, “I am an immigrant who, like many of my immigrant colleagues, feels proud to be contributing to my new country by working hard and creating new jobs for others…. Immigrant entrepreneurs have long been among America’s job creators and economy boosters. They have been core contributors to America’s past success and will be equally important to its future.”

In 2022, LabCentral and BioLabs received the Prix Galien Award in the incubators, accelerators, and equity category. Fruehauf’s numerous honors for his scientific and entrepreneurial work include recognition as EY Entrepreneur of the Year for the New England region and Immigrant Entrepreneur of the Year from the Immigrant Learning Center.

Published June 2026